Physician profile
Benjamin D Maclennan
NPI 1760696389
$4,457.63
in general payments reported to CMS, 2019-2025
7 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $15.97 · 2021: $799 · 2022: $237 · 2023: $1,611 · 2024: $24.01 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,236 · Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,235.51 |
| Food and Beverage | $524.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,387.60 | 2023-2024 | |
| Medtronic USA, INC. | $976.73 | 2019-2020 | |
| Medtronic, INC. | $933.87 | 2021-2023 | Capstone Ptc Spinal System, Catalyft Pl Expandable Interbody System |
| Amplify Surgical, INC. | $684.01 | 2019 | |
| Globus Medical, INC. | $235.50 | 2023-2025 | Hedron, Excelsiusgps Robotic Navigation System |
| Zimmer Biomet Holdings, INC. | $138.12 | 2022 | |
| Relievant Medsystems, INC. | $101.80 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,035,601.98 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Maclennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.